Trellis Bioscience, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-10-29.
Trellis Bioscience, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 29, 2026. Trellis Bioscience, Inc. was formerly named Trellis Bioscience LLC. The filing reports $9.09M sold. Its industry group is Biotechnology. It names Nora Mende (Chief Financial Officer), Larry Kauvar (Chief Science Officer) (SEC Form D/A, October 29, 2026).
Selling to Trellis Bioscience, Inc.? See who runs it and how to reach them, plus this week's 44 other newly funded companies.
Is this your company?
Sell to companies like Trellis Bioscience, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Trellis Bioscience, Inc.
Free to see. No signup.
More on the people and the money behind Trellis Bioscience, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in October 2026, largest first.
Get an email when Trellis Bioscience, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Trellis Bioscience, Inc. raises, hires or launches. No email unless you switch it on.
Watch Trellis Bioscience, Inc. →Get the full cited report on Trellis Bioscience, Inc.
What the filing shows about Trellis Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Trellis Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Trellis Bioscience, Inc.'s address as 702 Marshall Street, Suite 301, Redwood City, CA 94063.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Trellis Bioscience, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Trellis Bioscience, Inc. See pricing
Trellis Bioscience, Inc. is a registered filer with the SEC (CIK 1162015) and has filed since 2026-05-15. 6 filings are on record, the latest on 2026-10-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Trellis Bioscience, Inc.'s Form D of 2026-10-29 names Nora Mende and Larry Kauvar as its officers, directors or promoters.
Its new offerings report $35.41M sold across 5 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $9.09M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer.
Nora Mende is named as Chief Financial Officer on the Form D that Trellis Bioscience, Inc. filed with the SEC on 29 October 2026, one of 2 people that filing names.
On the filing as: Executive Officer.
Larry Kauvar is named as Chief Science Officer on the Form D that Trellis Bioscience, Inc. filed with the SEC on 29 October 2026, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2026-10-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Trellis Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Trellis Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Trellis Bioscience, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Trellis Bioscience, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Trellis Bioscience, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (trellisbio.com).
Each opens in a new tab, filled in for Trellis Bioscience, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/trellis-bioscience-inc-form-d-004073